QQ客服 官方微博 反馈留言

	Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival
	Zhang, Ying; Ji, Yajie; Li, Jianwei; Lei, Li; Wu, Siyu; Zuo, Wenjia; Jia, Xiaoqing; Wang, Yujie; Mo, Miao; Zhang, Na
刊名	BREAST CANCER RESEARCH AND TREATMENT
	2018
卷号	168期号:3
关键词	GnRHa Ovarian preservation Breast cancer Premenopausal ER-positive
ISSN号	0167-6806
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609971
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, Ying,Ji, Yajie,Li, Jianwei,et al. Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival[J]. BREAST CANCER RESEARCH AND TREATMENT,2018,168(3).
APA	Zhang, Ying.,Ji, Yajie.,Li, Jianwei.,Lei, Li.,Wu, Siyu.,...&Liu, Guangyu.(2018).Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.BREAST CANCER RESEARCH AND TREATMENT,168(3).
MLA	Zhang, Ying,et al."Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival".BREAST CANCER RESEARCH AND TREATMENT 168.3(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。